Actively Recruiting

Age: 1Year - 23Years
All Genders
NCT07422337

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

Led by Arkansas Children's Hospital Research Institute · Updated on 2026-02-25

300

Participants Needed

2

Research Sites

154 weeks

Total Duration

On this page

Sponsors

A

Arkansas Children's Hospital Research Institute

Lead Sponsor

C

Columbia University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to establish a clear vaccination protocol for pediatric patients (less than 21 years old) who have received treatment for B-cell Acute Lymphoblastic Leukemia/Lymphoma. The main study aims are: * Evaluate the persistence of protective immunity to routine childhood vaccinations in participants with B-ALL/Ly who have received blinatumomab. * To determine whether revaccination in participants with non-protective titers leads to restored humoral immunity. Researchers will compare results from participants who have received immunotherapy to those who have not received immunotherapy to see if immunotherapy versus other chemotherapeutic drugs adversely affect the protective immunity acquired through vaccination.

CONDITIONS

Official Title

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

Who Can Participate

Age: 1Year - 23Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of B-lineage acute lymphoblastic leukemia or lymphoma
  • Between 1 and 21 years old at diagnosis
  • Provided informed consent (and child assent if applicable)
  • Completed all vaccinations routinely given during the first year of life
Not Eligible

You will not qualify if you...

  • Relapsed or refractory disease at any time
  • Has received or will require bone marrow transplant or cellular therapy
  • Is pregnant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Arkansas Children's

Little Rock, Arkansas, United States, 72202

Actively Recruiting

2

Arkansas Children's Northwest

Springdale, Arkansas, United States, 72762

Actively Recruiting

Loading map...

Research Team

L

Lauren Appell, MD

CONTACT

S

Stephanie Thomas, RN

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here